Race Oncology

0 followers


Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.

Industries

Headquarters

Sydney, Australia

Employees

1-10

Links


Org chart

Daniel Tillett
Managing Director And Chief Executive Officer
Collapse
Sophia Moscovis
Vice President Of Operations & Strategy
Marinella Messina
Clinical Program Director

Board & advisors

Borje Andersson
Chair of Clinical Advisory Board
Peter Smith
Non-Executive Director